Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 11/20 | 0.55 |
| ▸ | IL17A | Q16552 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 10/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 8/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 8/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 8/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 8/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 8/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 8/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 8/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 8/20 | 0.53 |
| ▸ | PARP1 | P09874 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL148816 | 1.00 | BRD4 (0.55) | BRD4IL17AHDAC1HDAC3HDAC4 | |
| SCHEMBL30434624 | 0.89 | BRD4 (0.46) | BRD4IL17AHDAC1HDAC3HDAC4 | |
| SCHEMBL146531 | 0.89 | BRD4 (0.46) | BRD4IL17AHDAC1HDAC3HDAC4 | |
| SCHEMBL143261 | 0.88 | BRD4 (0.66) | BRD4IL17AHDAC1HDAC3HDAC4 | |
| SCHEMBL30434741 | 0.88 | BRD4 (0.66) | BRD4IL17AHDAC1HDAC3HDAC4 | |
| SCHEMBL146525 | 0.85 | BRD4 (0.57) | BRD4IL17AHDAC1HDAC3HDAC4 | |
| SCHEMBL30434806 | 0.85 | BRD4 (0.57) | BRD4IL17AHDAC1HDAC3HDAC4 | |
| SCHEMBL15551676 | 0.84 | BRD4 (0.54) | BRD4IL17AHDAC1HDAC3HDAC4 | |
| SCHEMBL378097 | 0.82 | BRD4 (0.50) | BRD4IL17AHDAC1HDAC3HDAC4 | |
| SCHEMBL347354 | 0.79 | BRD4 (0.74) | BRD4IL17AHDAC1HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107252429-B | Novel anti-inflammatory agent | 雷斯韦洛吉克斯公司 | 2023-06-16 | — | — | CN | disclosed |